These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5538853)

  • 21. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract]   [Full Text] [Related]  

  • 22. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
    Puca FM; Megna GF; Masi G; Specchio LM
    Riv Patol Nerv Ment; 1974 Oct; 95(5):676-84. PubMed ID: 4470268
    [No Abstract]   [Full Text] [Related]  

  • 23. Start hesitation--a side effect of long-term levodopa therapy.
    Ambani LM; Van Woert MH
    N Engl J Med; 1973 May; 288(21):1113-5. PubMed ID: 4697941
    [No Abstract]   [Full Text] [Related]  

  • 24. L-dopa, parkinsonism, and depression.
    Damásio AR; Antunes JL; Macedo C
    Lancet; 1970 Sep; 2(7673):611-2. PubMed ID: 4195576
    [No Abstract]   [Full Text] [Related]  

  • 25. The Eaton collaborative study of levodopa therapy in parkinsonism: a summary.
    Keenan RE
    Neurology; 1970 Dec; 20(12):Suppl:46-65. PubMed ID: 5529915
    [No Abstract]   [Full Text] [Related]  

  • 26. Parkinson's disease and levodopa. A five-year follow-up and review.
    Markham CH; Treciokas LJ; Diamond SG
    West J Med; 1974 Sep; 121(3):188-206. PubMed ID: 4606887
    [No Abstract]   [Full Text] [Related]  

  • 27. Reappraisal of levodopa therapy for Parkinson's disease. A three-year experience with outpatients in private practice.
    McFarland HR
    Mo Med; 1974 Sep; 71(9):535-7. PubMed ID: 4854038
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma concentration of levodopa in patients with Parkinson's disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1973; 10(5):301-10. PubMed ID: 4789106
    [No Abstract]   [Full Text] [Related]  

  • 29. Side effects from levodopa.
    Ray I
    Can Med Assoc J; 1972 Jul; 107(1):19. PubMed ID: 5042883
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse reactions during treatment of Parkinson's disease with levodopa.
    Martin WE
    JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258
    [No Abstract]   [Full Text] [Related]  

  • 31. Sustained-release levodopa in Parkinsonism.
    Curzon G; Friedel J; Grier L; Marsden CD; Parkes JD; Shipley M; Zilkha KJ
    Lancet; 1973 Apr; 1(7806):781. PubMed ID: 4120768
    [No Abstract]   [Full Text] [Related]  

  • 32. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
    McDowell F; Lee JE; Swift T; Sweet RD; Ogsbury JS; Kessler JT
    Ann Intern Med; 1970 Jan; 72(1):29-35. PubMed ID: 5410397
    [No Abstract]   [Full Text] [Related]  

  • 34. Levodopa in parkinsonism.
    Practitioner; 1972 May; 208(247):695-9. PubMed ID: 4560973
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa treatment of Parkinson's syndrome. Improved intellectual functioning.
    Loranger AW; Goodell H; Lee JE; McDowell F
    Arch Gen Psychiatry; 1972 Feb; 26(2):163-8. PubMed ID: 5060402
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhanced response to low doses of levodopa after withdrawal from chronic treatment.
    Sweet RD; Lee JE; Speigel HE; McDowell F
    Neurology; 1972 May; 22(5):520-5. PubMed ID: 4673448
    [No Abstract]   [Full Text] [Related]  

  • 37. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
    Calne DB; Reid JL; Vakil SD; Rao S; Petrie A; Pallis CA; Gawler J; Thomas PK; Hilson A
    Br Med J; 1971 Sep; 3(5777):729-32. PubMed ID: 4938431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
    Serby M; Angrist B; Lieberman A
    Am J Psychiatry; 1978 Oct; 135(10):1227-9. PubMed ID: 29497
    [No Abstract]   [Full Text] [Related]  

  • 39. Mental symptoms in Parkinsonian patients treated with L-dopa.
    Jenkins RB; Groh RH
    Lancet; 1970 Jul; 2(7665):177-9. PubMed ID: 4193568
    [No Abstract]   [Full Text] [Related]  

  • 40. [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
    Sano I; Taniguchi K
    Munch Med Wochenschr; 1972 Oct; 114(40):1717-9. PubMed ID: 4538893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.